MEDEZE Showcases Performance at Opportunity Day Year-End 2025 Aiming to Create a New S-Curve from ATMPs
Ms. Anchisa Lekpetch (right), Chief Accounting and Financial Officer, and Dr. Wasawat Sroithong (left), Investor Relations Officer of Medeze Group Public Company Limited (MEDEZE), presented the company’s information and operating results for the year 2025 at the Opportunity Day event, organized by the Stock Exchange of Thailand for listed companies to meet with investors.
For 2025, the company reported total revenue of THB 776.41 million and net profit of THB 196.38 million, reflecting its effective cost management and strong ability to maintain profitability. The company continues to focus on expanding its Advanced Therapy Medicinal Products (ATMPs) business, growing its international Biobank network, and developing medical research and innovation projects to create a New S-Curve and drive sustainable long-term growth.
For more information, please visit:https://www.medezegroup.com/th/
IR Press Releases